Hiroyoko Moritoyo

417 total citations
10 papers, 202 citations indexed

About

Hiroyoko Moritoyo is a scholar working on Immunology, Neurology and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, Hiroyoko Moritoyo has authored 10 papers receiving a total of 202 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Neurology and 3 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in Hiroyoko Moritoyo's work include T-cell and Retrovirus Studies (4 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Vector-Borne Animal Diseases (3 papers). Hiroyoko Moritoyo is often cited by papers focused on T-cell and Retrovirus Studies (4 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Vector-Borne Animal Diseases (3 papers). Hiroyoko Moritoyo collaborates with scholars based in Japan and United States. Hiroyoko Moritoyo's co-authors include Takashi Moritoyo, Mitsuhiro Osame, Shuji Izumo, Todd A. Reinhart, Ashley T. Haase, Eiichi Sato, Masahiro Nagai, Yuetsu Tanaka, Koichiro Usuku and Masaru Sorimachi and has published in prestigious journals such as Annals of Neurology, Electroencephalography and Clinical Neurophysiology and Journal of the Neurological Sciences.

In The Last Decade

Hiroyoko Moritoyo

10 papers receiving 198 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroyoko Moritoyo Japan 6 163 93 85 22 17 10 202
K. Usuku Japan 7 142 0.9× 72 0.8× 72 0.8× 5 0.2× 15 0.9× 15 172
Davimar Miranda Maciel Borducchi Brazil 6 88 0.5× 50 0.5× 56 0.7× 5 0.2× 4 0.2× 11 144
Isabelle Allard France 2 85 0.5× 48 0.5× 58 0.7× 1 0.0× 15 0.9× 3 120
Max A. Pfost United States 4 66 0.4× 6 0.1× 2 0.0× 3 0.1× 23 1.4× 4 130
J. Deschacht Belgium 8 121 0.7× 32 0.3× 3 0.0× 19 1.1× 9 449
Matthew W. Hahn United States 2 25 0.2× 4 0.0× 9 0.1× 1 0.0× 53 3.1× 2 125
E. Gloria C. Regisford United States 3 40 0.2× 36 0.4× 3 0.0× 25 1.5× 6 113
R.J. Partridge United Kingdom 7 28 0.2× 66 0.7× 4 0.0× 187 11.0× 7 435
K. Kallianidis Greece 12 92 0.6× 28 0.3× 3 0.0× 133 7.8× 21 492
Kreepa Kooblall United Kingdom 7 7 0.0× 4 0.0× 16 0.2× 13 0.6× 60 3.5× 11 113

Countries citing papers authored by Hiroyoko Moritoyo

Since Specialization
Citations

This map shows the geographic impact of Hiroyoko Moritoyo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyoko Moritoyo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyoko Moritoyo more than expected).

Fields of papers citing papers by Hiroyoko Moritoyo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyoko Moritoyo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyoko Moritoyo. The network helps show where Hiroyoko Moritoyo may publish in the future.

Co-authorship network of co-authors of Hiroyoko Moritoyo

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyoko Moritoyo. A scholar is included among the top collaborators of Hiroyoko Moritoyo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyoko Moritoyo. Hiroyoko Moritoyo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Nomoto, Masahiro, Noriko Nishikawa, Masahiro Nagai, et al.. (2009). Inter- and intra-individual variation in L-dopa pharmacokinetics in the treatment of Parkinson's disease. Parkinsonism & Related Disorders. 15. S21–S24. 10 indexed citations
2.
Nagai, Masahiro, Noriko Nishikawa, Hayato Yabe, et al.. (2007). Dopamine agonists and valvular heart disease in Japanese patients with Parkinson's disease. Journal of Neurology. 254(S4). IV54–IV57. 1 indexed citations
3.
Nagai, Masahiro, Hayato Yabe, Noriko Nishikawa, et al.. (2006). Effect of Clarithromycin on the Pharmacokinetics of Cabergoline in Healthy Controls and in Patients With Parkinson’s Disease. Journal of Pharmacological Sciences. 100(1). 59–64. 14 indexed citations
4.
Nomoto, Masahiro, Masahiro Nagai, Noriko Nishikawa, et al.. (2006). Pharmacokinetic characteristics of agents applied in the treatment of Parkinson’s disease. Journal of Neurology. 253(S3). iii53–iii59. 4 indexed citations
5.
Nomoto, Masahiro, et al.. (2005). [Inter- and intraindividual pharmacokinetic variations in the treatment of Parkinson's disease].. PubMed. 45(11). 895–8. 1 indexed citations
6.
Moritoyo, Takashi, Shuji Izumo, Hiroyoko Moritoyo, et al.. (1999). Detection of human T-lymphotropic virus type I p40taxprotein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. Journal of NeuroVirology. 5(3). 241–248. 54 indexed citations
7.
Moritoyo, Hiroyoko, et al.. (1996). Study of lower limb somatosensory evoked potentials in 96 cases of HTLV-I-associated myelopathy/tropical spastic paraparesis. Journal of the Neurological Sciences. 138(1-2). 78–81. 17 indexed citations
8.
Moritoyo, Takashi, Todd A. Reinhart, Ashley T. Haase, et al.. (1996). Human T‐lymphotropic virus type I‐associated myelopathy and tax gene expression in CD4+ T lymphocytes. Annals of Neurology. 40(1). 84–90. 89 indexed citations
9.
Arimura, Kimiyoshi, Hiroyoko Moritoyo, Yoshika Tokimura, et al.. (1995). How helpful is thoracic paraspinal EMG in HAM/TSP?. Muscle & Nerve. 18(2). 248–250. 11 indexed citations
10.
Arimura, Kimiyoshi, Yoshika Tokimura, Hiroyoko Moritoyo, et al.. (1993). Neuropathy in HTLV-I associated myelopathy (HAM). Electroencephalography and Clinical Neurophysiology. 87(2). S61–S61. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. Usuku Breakdown of academic impact, for papers by Davimar Miranda Maciel Borducchi Breakdown of academic impact, for papers by Isabelle Allard Breakdown of academic impact, for papers by Max A. Pfost Breakdown of academic impact, for papers by J. Deschacht Breakdown of academic impact, for papers by Matthew W. Hahn Breakdown of academic impact, for papers by E. Gloria C. Regisford Breakdown of academic impact, for papers by R.J. Partridge Breakdown of academic impact, for papers by K. Kallianidis Breakdown of academic impact, for papers by Kreepa Kooblall
Rankless by CCL
2026